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Introduction
There are currently no agreed recommendations on how
to investigate children for cardiopulmonary involvement
in Juvenile Systemic Sclerosis (JSSc). The aim of screening
is to detect disease early to facilitate early aggressive ther-
apy and improve outcomes. Cardiopulmonary involvement
is the leading cause of death in JSSc and cardiopulmonary
at diagnosis incurs a worse outcome [1]. Most deaths
occur early in the disease course [1, 2].
Objectives
To develop recommendations for investigation of cardi-
opulmonary in JSSc, based on paediatric evidence and
where this was lacking, consensus expert agreement.
Methods
Members of the PRES Scleroderma Working Group were
invited to participate; additionally a paediatric cardiologist
was invited. A nominal group technique was used.
75% consensus was defined as agreement.
Results
Table 1 shows the recommendations for screening for
cardiopulmonary at baseline and at defined time points
from diagnosis. Other recommendations agreed by the
group which are relevant at any stage in the disease
course are as follows (in Table 1).
Recommendations are based on low grade evidence
and in the most part from expert consensus opinion
with extrapolation from adult studies.
Conclusion
JSSc has a significant mortality particularly early on in
the disease course. The objective of an aggressive
screening program is to identify cardiopulmonary invol-
vement at a stage which may be amenable to treatment.
The recommendations developed by this group aim to
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Table 1 Recommendations for screening for
cardiopulmonary involvement in JSSc at baseline and
follow-up (75% consensus defined as agreement)
Cardiopulmonary Baseline
All patients should undergo:
- BP
- 12 lead ECG
- 24 hour ECG
- ECHO with Doppler
- Cardiac MRI with gadolinium
- HRCT thorax
- PFT with DLCO
- 6MWT
Follow-up screening (for first 5 years from
diagnosis)*





At 3 years Repeat HRCT
*screening guidelines are based on asymptomatic patients. However, children
may need more frequent monitoring depending on clinical status and
abnormalities detected on previous investigation.
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Abbreviations
BP: blood pressure; ECG: electrocardiogram; ECHO: echocardiogram; MRI:
magnetic resonance imaging; HRCT: high resolution computerised
tomography; PFT DLCO: pulmonary function tests with diffusion capacity of
lung for carbon monoxide; 6MWT: 6 minute walk test; NT BNP: N-terminal
pro-brain natriuretic peptide; GORD: gastro-oesophageal reflux disease.
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